A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia

Synexus Clinical Research US, Inc., Jamaica

Neurobehavioral Research, Inc., Cedarhurst

CBH Health, LLC, Gaithersburg

Carolina Clinical Trials, Inc., Charleston

Synexus Clinical Research US, Inc., Atlanta

Atlanta Center for Medical Research, Atlanta

Behavioral Clinical Research, Inc., North Miami

Innovative Clinical Research, Inc., Lauderhill

Uptown Research Institute, LLC, Chicago

Pillar Clinical Research, LLC, Lincolnwood

Arch Clinical Trials, LLC, St Louis

Woodland International Research Group, LLC, Little Rock

Woodland Research Northwest, LLC, Rogers

Pillar Clinical Research, LLC, Richardson

InSite Clinical Research, LLC, DeSoto

Donald J. Garcia Jr., MD, PA, Austin

Community Clinical Research, Inc., Austin

Altea Research Institute, Las Vegas

ProScience Research Group, Culver City

Collaborative Neuroscience Network, LLC, Torrance

Synexus Clinical Research US, Inc., Cerritos

Synergy San Diego, Lemon Grove

Collaborative Neuroscience Network, LLC, Garden Grove

Pacific Research Partners, LLC, Oakland

Hassman Research Institute, Berlin

Hassman Research Institute, Marlton